Fundz

NorthStar Medical Technologies Secures Up to $185 Million Growth Financing Led by Hercules Capital to Scale Actinium-225 Production for Precision Cancer Therapies.

PRIVATESep 29, 2026

Amount Raised

$185 Million

Round Type

Debt Financing

BeloitBiotechnologyHealth CareMedicalMedical Device

Investors

Hercules Capital, Inc.

Description

NorthStar Medical Technologies has announced a multi-year growth capital facility of up to $185 million with Hercules Capital. The financing will include $100 million upfront to accelerate investment in isotope production. The funds will support NorthStar’s growth and expansion initiatives. The capital aims to boost production capabilities for nex-generation precision cancer therapies.

Quick answer

NorthStar Medical Technologies raised $185 Million in a Debt Financing round, dated September 29, 2026. Investors: Hercules Capital, Inc. NorthStar Medical Technologies is based in Beloit, Wisconsin, United States.

How much did NorthStar Medical Technologies raise?
NorthStar Medical Technologies raised $185 Million in a Debt Financing round on September 29, 2026.
Who invested in NorthStar Medical Technologies?
Hercules Capital, Inc. is named as investors in this round.
What does NorthStar Medical Technologies do?
NorthStar Medical Technologies, LLC is the first commercial-scale producer of no-carrier-added actinium-225 (n.c.a.
Where is NorthStar Medical Technologies based and how big is it?
NorthStar Medical Technologies is based in Beloit, Wisconsin, United States. Fundz records about 11 employees.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as NorthStar Medical Technologies that raised within 45 days of this round, from Fundz verified event records.

  • Skribe Medical raised $1.6M (Pre-Seed) on November 12, 2026.
  • EnVision Endoscopy raised $12M (Series A) on November 10, 2026.
  • Laza Medical raised $160M (Series B) on November 4, 2026.
  • Picard Medical raised $1.2M (Funding Round) on November 3, 2026.
  • StimCardio raised $30M (Series A) on October 29, 2026.
  • Impress raised $45M (Debt Financing) on October 27, 2026.

Who to call at NorthStar Medical Technologies, and when

A new round usually means NorthStar Medical Technologies is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NorthStar Medical Technologies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NorthStar Medical Technologies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NorthStar Medical Technologies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NorthStar Medical Technologies

Location

Beloit, Wisconsin, United States

About

NorthStar Medical Technologies, LLC is the first commercial-scale producer of no-carrier-added actinium-225 (n.c.a. Ac-225) using electron-accelerator technology. The company focuses on the production of radiopharmaceuticals for next-generation precision cancer therapies. With a commitment to growth and expansion, NorthStar is enhancing its capabilities in isotope production. Their innovative approach aims to significantly impact the field of cancer treatment.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NorthStar Medical Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for NorthStar Medical Technologies's next move

See what Strategic adds

NorthStar Medical Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.